Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

References for PMC Articles for PubMed (Select 11546803)

1.
2.

Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.

Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G.

EMBO J. 2001 Jul 16;20(14):3760-70.

3.

Gene suppression by tristetraprolin and release by the p38 pathway.

Zhu W, Brauchle MA, Di Padova F, Gram H, New L, Ono K, Downey JS, Han J.

Am J Physiol Lung Cell Mol Physiol. 2001 Aug;281(2):L499-508.

4.

The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR.

Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J.

Mol Cell Biol. 2001 Feb;21(3):721-30. Erratum in: Mol Cell Biol. 2005 Apr;25(8):3400.

5.

p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.

van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, Peppelenbosch MP.

J Immunol. 2001 Jan 1;166(1):582-7.

6.
7.

TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha.

Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P.

EMBO J. 2000 Aug 1;19(15):4154-63.

8.

MAP kinase pathways activated by stress: the p38 MAPK pathway.

Obata T, Brown GE, Yaffe MB.

Crit Care Med. 2000 Apr;28(4 Suppl):N67-77. Review.

PMID:
10807318
9.

Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway.

Stoecklin G, Ming XF, Looser R, Moroni C.

Mol Cell Biol. 2000 Jun;20(11):3753-63.

11.
13.

New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.

Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R.

J Med Chem. 1999 Nov 18;42(23):4890-908.

PMID:
10579851
14.

Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase.

Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, Manthey CL.

Inflamm Res. 1999 Oct;48(10):533-8.

PMID:
10563470
15.

MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.

Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M.

Nat Cell Biol. 1999 Jun;1(2):94-7.

PMID:
10559880
16.

RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, Siekierka JJ.

J Pharmacol Exp Ther. 1999 Nov;291(2):680-7.

17.

p38 MAPK signalling cascades in inflammatory disease.

Herlaar E, Brown Z.

Mol Med Today. 1999 Oct;5(10):439-47. Review.

PMID:
10498912
18.

Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.

Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, Wallach D, Malinin NL, Cooper JA, Resch K, Kracht M.

Mol Cell Biol. 1999 Oct;19(10):6742-53.

19.

The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.

Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Müller M, Gaestel M, Resch K, Holtmann H.

EMBO J. 1999 Sep 15;18(18):4969-80.

20.

Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ.

Mol Cell Biol. 1999 Jun;19(6):4311-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk